Learning Objectives:

1. Discuss the rising incidence of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

2. Discuss the role of liver transplantation in both HCC and CCA

3. Discuss the importance of a multidisciplinary team approach to treatment of hepatobiliary malignancies

4. Discuss the genomic landscape of biliary tract cancers

5. Discuss the role of targeted therapy in biliary tract cancers

6. Discuss the role of immunotherapy in biliary tract cancers

7. Define roles of Intra-arterial therapies for liver cancer treatment

8. Discuss percutaneous ablation as a non-vascular method for treating liver cancer

9. Review latest data on combination therapies using interventional treatments with immunotherapy and chemotherapeutics


Session date: 
11/19/2020 - 4:00pm to 5:00pm CST
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Anjana Pillai, MD: Medical Director of Liver Tumor Program